| Product Code: ETC9551057 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Cell And Gene Therapy Clinical Trial Services Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Cell And Gene Therapy Clinical Trial Services Market - Industry Life Cycle |
3.4 Sweden Cell And Gene Therapy Clinical Trial Services Market - Porter's Five Forces |
3.5 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Phase, 2021 & 2031F |
3.7 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Therapeutic Areas, 2021 & 2031F |
3.8 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
4 Sweden Cell And Gene Therapy Clinical Trial Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in cell and gene therapy research and development in Sweden |
4.2.2 Supportive government initiatives and policies promoting clinical trials in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for cell and gene therapy clinical trials |
4.3.2 Limited availability of skilled professionals and infrastructure for conducting clinical trials in Sweden |
5 Sweden Cell And Gene Therapy Clinical Trial Services Market Trends |
6 Sweden Cell And Gene Therapy Clinical Trial Services Market, By Types |
6.1 Sweden Cell And Gene Therapy Clinical Trial Services Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Site Identification, 2021- 2031F |
6.1.4 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Patient Recruitment, 2021- 2031F |
6.1.5 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Laboratory Services, 2021- 2031F |
6.1.6 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Regulatory Services, 2021- 2031F |
6.1.7 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Supply and Logistic Services, 2021- 2031F |
6.1.8 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Sweden Cell And Gene Therapy Clinical Trial Services Market, By Phase |
6.2.1 Overview and Analysis |
6.2.2 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase I, 2021- 2031F |
6.2.3 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase II, 2021- 2031F |
6.2.4 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase III, 2021- 2031F |
6.2.5 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase IV, 2021- 2031F |
6.3 Sweden Cell And Gene Therapy Clinical Trial Services Market, By Therapeutic Areas |
6.3.1 Overview and Analysis |
6.3.2 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.3 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Central Nervous System (CNS) Disorders, 2021- 2031F |
6.3.4 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.5 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.3.6 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Musculoskeletal, 2021- 2031F |
6.3.7 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Sweden Cell And Gene Therapy Clinical Trial Services Market, By Therapy Type |
6.4.1 Overview and Analysis |
6.4.2 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.4.3 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Gene-modified Cell Therapy, 2021- 2031F |
6.4.4 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.4.5 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden Cell And Gene Therapy Clinical Trial Services Market Import-Export Trade Statistics |
7.1 Sweden Cell And Gene Therapy Clinical Trial Services Market Export to Major Countries |
7.2 Sweden Cell And Gene Therapy Clinical Trial Services Market Imports from Major Countries |
8 Sweden Cell And Gene Therapy Clinical Trial Services Market Key Performance Indicators |
8.1 Patient recruitment rate for cell and gene therapy clinical trials in Sweden |
8.2 Number of partnerships between research institutions and biopharmaceutical companies in the cell and gene therapy sector |
8.3 Success rate of cell and gene therapy clinical trials in terms of meeting endpoints and demonstrating efficacy. |
9 Sweden Cell And Gene Therapy Clinical Trial Services Market - Opportunity Assessment |
9.1 Sweden Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 Sweden Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Phase, 2021 & 2031F |
9.3 Sweden Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Therapeutic Areas, 2021 & 2031F |
9.4 Sweden Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
10 Sweden Cell And Gene Therapy Clinical Trial Services Market - Competitive Landscape |
10.1 Sweden Cell And Gene Therapy Clinical Trial Services Market Revenue Share, By Companies, 2024 |
10.2 Sweden Cell And Gene Therapy Clinical Trial Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here